Aims and Scope of Current Gene Therapy
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less
Key Metrics
CiteScore 

5.8
Eigenfactor 

0.001 - 0.005
Impact Factor 

< 5
SJR 

Q3Genetics

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on Current Gene Therapy
Current Gene Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Gene Therapy
Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.
- 17 Jun 2026
- Current gene therapy
GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.
- 15 Jun 2026
- Current gene therapy
Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.
- 1 Jun 2026
- Current gene therapy
Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.
- 1 Jun 2026
- Current gene therapy
A Telomere-Maintenance Three-Gene Model for the Prognostic Prediction in Intrahepatic Cholangiocarcinoma and Multi-Cohort Validation.
- 30 May 2026
- Current gene therapy
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer.
- 25 May 2026
- Current gene therapy
Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.
- 17 Jun 2026
- Current gene therapy
GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.
- 15 Jun 2026
- Current gene therapy
Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.
- 1 Jun 2026
- Current gene therapy
Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.
- 1 Jun 2026
- Current gene therapy
A Telomere-Maintenance Three-Gene Model for the Prognostic Prediction in Intrahepatic Cholangiocarcinoma and Multi-Cohort Validation.
- 30 May 2026
- Current gene therapy
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer.
- 25 May 2026
- Current gene therapy